Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
WAB heads into Tuesday's Q3 results carrying a stock that has outpaced its industrial peers by a wide margin, while the options market has quietly turned more constructive in recent weeks.
The shift in options positioning is the clearest signal into the print. The put/call ratio has dropped to 0.70, slightly below its 20-day average of 0.74, and a full standard deviation beneath where it was trading through September, when the PCR ran above 0.89 consistently. That earlier defensiveness has unwound. The borrow market tells a similar story: availability is exceptionally loose, with more than 100 shares available to lend for every one currently borrowed, and cost to borrow sits at a negligible 0.56%. Short interest has edged higher over the past month, up roughly 13%, but at just 2% of the free float it remains a low-conviction position. There is no squeeze pressure, and no sign of a crowded bear trade.
The analyst community is broadly positive but not uniformly so, and the divergence matters. Citigroup maintained its Buy rating on October 8 while trimming its target modestly to $338, a signal of confidence tempered by a slightly more cautious near-term view. JP Morgan remains at Neutral with a $320 target, sitting below the current price of $286.82 but reflecting a Street that has been lifting its sights: the mean consensus target is $330, implying roughly 15% upside from here. The bull case centres on a $22 billion backlog, expanding international exposure, and digital intelligence investments that are expected to compound organic growth over several years. Bears counter that EPS estimates have been revised lower across FY25 to FY27, and that a broader industrial slowdown or weakening in domestic locomotive markets would remove the demand floor the bulls are relying on.
One data point worth noting on the ownership side: FMR (Fidelity) added just over 2 million shares in the most recent quarter and now holds 10.9% of the company, the largest declared stake on the register. BlackRock and Vanguard entities are also sizeable holders. None of the 13D/G filings on record carry activist intent. The recent insider activity from CEO Rafael Santana, roughly $520,000 in aggregate sales over October 5 and 6, is low signal: all transactions were pre-arranged under a 10b5-1 plan and individually small.
The last quarterly print, in July, saw the stock jump more than 13% on the day and hold most of that gain through the following week, a reaction that reset analyst targets sharply higher across the board. The coming print will test whether that momentum and the $22 billion backlog can deliver the kind of organic revenue growth needed to justify a P/E above 23x in an environment where several correlated peers have pulled back this month.
See the live data behind this article on ORTEX.
Open WAB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
